Sophiris Bio Reports Encouraging Preliminary Data from Phase 2a Proof of …

Sophiris Bio Reports Encouraging Preliminary Data from Phase 2a Proof of …

The ongoing Phase 2a proof of concept study is a single-center, open-label study at University College London, which is well known for the focal treatment of prostate cancer in the UK. In this study, previously obtained multiparametric magnetic

(Visited 2 times, 1 visits today)
6
Like
Save

Comments

Comments are disabled for this post.